Document is current
Any future updates will be listed below
-
Authors
Gibson, Deanna L. https://orcid.org/0000-0003-0052-7550
- License Information
-
More Information
Article History
First Online: 2 October 2025
Competing interests
: D.L.G. is a co-founder of Melius MicroBiomics, a University of British Columbia (UBC) spin-off company that has licenced the UBC technology under the following patents: PCT/CA2018/050188, D.L. Gibson, A. Godovanny, S.K. Gill, A. Verdugo, Designer probiotics engineered to efficiently colonize the gut for effective inflammatory bowel disease (IBD) therapy, Tech Transfer October 2024 with Melius MicroBiomics; and 63/704,043 (patent pending). D.L.G. has founding shares in Melius MicroBiomics.
